Thorsten Steiner
Thorsten Steiner
Professor Neurology, Heidelberg University & Copenhagen University & Klinikum Höchst
Verified email at
Cited by
Cited by
Idarucizumab for dabigatran reversal
CV Pollack Jr, PA Reilly, J Eikelboom, S Glund, P Verhamme, ...
New England Journal of Medicine 373 (6), 511-520, 2015
Recombinant activated factor VII for acute intracerebral hemorrhage
SA Mayer, NC Brun, K Begtrup, J Broderick, S Davis, MN Diringer, ...
New England Journal of Medicine 352 (8), 777-785, 2005
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage
SA Mayer, NC Brun, K Begtrup, J Broderick, S Davis, MN Diringer, ...
New England Journal of Medicine 358 (20), 2127-2137, 2008
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
SM Davis, J Broderick, M Hennerici, NC Brun, MN Diringer, SA Mayer, ...
Neurology 66 (8), 1175-1181, 2006
European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage
T Steiner, S Juvela, A Unterberg, C Jung, M Forsting, G Rinkel
Cerebrovascular diseases 35 (2), 93-112, 2013
Idarucizumab for dabigatran reversal—full cohort analysis
CV Pollack Jr, PA Reilly, J Van Ryn, JW Eikelboom, S Glund, ...
New England Journal of Medicine 377 (5), 431-441, 2017
Early hemicraniectomy in patients with complete middle cerebral artery infarction
S Schwab, T Steiner, A Aschoff, S Schwarz, HH Steiner, O Jansen, ...
Stroke 29 (9), 1888-1893, 1998
European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage
T Steiner, RAS Salman, R Beer, H Christensen, C Cordonnier, L Csiba, ...
International journal of stroke 9 (7), 840-855, 2014
Intensive blood-pressure lowering in patients with acute cerebral hemorrhage
AI Qureshi, YY Palesch, WG Barsan, DF Hanley, CY Hsu, RL Martin, ...
New England Journal of Medicine 375 (11), 1033-1043, 2016
Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic?
C Berger, M Fiorelli, T Steiner, WR Schäbitz, L Bozzao, E Bluhmki, ...
Stroke 32 (6), 1330-1335, 2001
Recommendations for the management of intracranial haemorrhage-part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing …
T Steiner, M Kaste, M Forsting, D Mendelow, H Kwiecinski, I Szikora, ...
Cerebrovascular diseases (Basel, Switzerland) 22 (4), 294-316, 2006
Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN
N Wahlgren, T Moreira, P Michel, T Steiner, O Jansen, C Cognard, ...
International Journal of Stroke 11 (1), 134-147, 2016
Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions
T Steiner, J Rosand, M Diringer
Stroke 37 (1), 256-262, 2006
Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies …
HB Huttner, PD Schellinger, M Hartmann, M Köhrmann, E Juettler, ...
Stroke 37 (6), 1465-1470, 2006
Determinants of intracerebral hemorrhage growth: an exploratory analysis
JP Broderick, MN Diringer, MD Hill, NC Brun, SA Mayer, T Steiner, ...
Stroke 38 (3), 1072-1075, 2007
Extending thrombolysis to 4.5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
BC Campbell, H Ma, S Curtze, GA Donnan, M Kaste
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion
MI Aguilar, RG Hart, CS Kase, WD Freeman, BJ Hoeben, RC García, ...
Mayo Clinic Proceedings 82 (1), 82-92, 2007
Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial
T Steiner, S Poli, M Griebe, J Hüsing, J Hajda, A Freiberger, M Bendszus, ...
The Lancet Neurology 15 (6), 566-573, 2016
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant …
T Steiner, MN Diringer, D Schneider, SA Mayer, K Begtrup, J Broderick, ...
Neurosurgery 59 (4), 767-774, 2006
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage
SA Mayer, NC Brun, J Broderick, S Davis, MN Diringer, BE Skolnick, ...
Stroke 36 (1), 74-79, 2005
The system can't perform the operation now. Try again later.
Articles 1–20